Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E63.80 EPS (ttm)0.72 Insider Own0.30% Shs Outstand1.72B Perf Week3.35%
Market Cap78.45B Forward P/E16.60 EPS next Y2.75 Insider Trans4.97% Shs Float1.72B Perf Month13.32%
Income1.06B PEG5.68 EPS next Q0.43 Inst Own65.10% Short Float0.77% Perf Quarter20.67%
Sales20.85B P/S3.76 EPS this Y-58.60% Inst Trans1.31% Short Ratio1.45 Perf Half Y7.17%
Book/sh13.89 P/B3.29 EPS next Y12.19% ROA3.30% Target Price47.46 Perf Year18.18%
Cash/sh10.93 P/C4.18 EPS next 5Y11.24% ROE6.80% 52W Range36.07 - 45.51 Perf YTD19.70%
Dividend1.06 P/FCF144.48 EPS past 5Y0.00% ROI6.70% 52W High0.37% Beta1.44
Dividend %2.32% Quick Ratio3.70 Sales past 5Y-0.50% Gross Margin56.80% 52W Low26.64% ATR0.58
Employees75000 Current Ratio4.00 Sales Q/Q2.80% Oper. Margin15.30% RSI (14)86.73 Volatility1.18% 1.37%
OptionableYes Debt/Eq1.05 EPS Q/Q11.00% Profit Margin6.70% Rel Volume0.83 Prev Close45.40
ShortableYes LT Debt/Eq1.01 EarningsJan 25 BMO Payout109.70% Avg Volume9.14M Price45.68
Recom1.90 SMA206.14% SMA5011.83% SMA20013.04% Volume7,593,098 Change0.62%
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Feb-24-17 07:39AM  Performance of Eli Lilly & Co.s Business Segments in 4Q16
Feb-23-17 05:08PM  2 Dividend Aristocrats Trading At A Discount
04:47PM  Abbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes at Moody's
01:52PM  FTC Settles Charges of Anti-Competition in Abbot, St. Jude Deal
01:04PM  ABBOTT LABORATORIES Financials
Feb-22-17 05:58PM  Abbott Laboratories Declares Quarterly Dividend
01:01PM  EU mergers and takeovers (Feb 22) Reuters
Feb-21-17 08:55AM  Abbott Commences Exchange Offers and Consent Solicitations for St. Jude Medical, LLC Notes PR Newswire
08:26AM  ABBOTT LABORATORIES Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements an
Feb-17-17 04:05PM  ABBOTT LABORATORIES Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial St
11:25AM  Abbott Declares 373rd Consecutive Quarterly Dividend PR Newswire
Feb-15-17 08:30AM  Real-World Data from Abbott's FreeStyle┬« Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes PR Newswire
Feb-14-17 05:40PM  Dysfunction, Heartbreak And Love: 11 Most Interesting Corporate Couples
Feb-12-17 03:09PM  Abbott Laboratories may see boost from St. Jude's acquisition: Barron's
10:29AM  5 Trade Ideas for Monday: Abbott Labs, ARRIS, BorgWarner, Lockheed and Nasdaq
Feb-11-17 12:01AM  [$$] Prognosis on Abbott Labs' Stock: 20% Return at Barrons.com
Feb-08-17 01:23PM  High-Powered Insiders Are Buying These 5 Stocks; Should You?
Feb-07-17 03:58PM  Dept. of Homeland Security Provides A Timely Update On Abbott, St. Jude
Feb-06-17 01:30PM  Locust Wood Boosts Exposure to These Companies at Insider Monkey
Feb-04-17 01:16AM  Insider Buys Highlight for Week of Jan. 30
Feb-03-17 11:36PM  [$$] Robert Schoellhorn Found New Career After Serving as Abbott Labs CEO at The Wall Street Journal
10:52AM  Abbott Laboratories (ABT)s Molecular Test For Detecting Zika Virus Approved By The FDA at Insider Monkey
05:30AM  [$$] Robert Schoellhorn Found New Career After Serving as Abbott Labs CEO at The Wall Street Journal
Feb-02-17 04:09PM  No "Sophomore Slump" Ahead For Boston Scientific at Barrons.com
12:13PM  ETFs with exposure to Abbott Laboratories : February 2, 2017
12:01PM  Abbott Laboratories (ABT) Pacemakers Get FDA Approval at Insider Monkey
11:53AM  FDA Approves Abbott Labs' Devices for MRI Scans
11:22AM  Edwards Lifesciences Sinks 9%; Is This A Buying Opportunity? at Barrons.com
08:00AM  U.S. FDA Grants Abbott the First Commercial Authorization for a Molecular Test to Detect Zika Virus Using Whole Blood PR Newswire
Feb-01-17 08:00AM  Abbott Announces U.S. Approval for its Assurity MRI Pacemaker, the World's Smallest, Longest-Lasting Wireless MRI-Compatible Pacemaker PR Newswire
Jan-30-17 07:36AM  Johnson & Johnsons 4Q16 Earnings: Major Developments
Jan-27-17 11:52AM  AbbVie Reports 4th-Quarter 2016 Results
Jan-26-17 01:35PM  Changes in Johnson & Johnsons Growth Rate in 4Q16
11:47AM  J&J to spend $30 billion on Swiss drugmaker Actelion
11:36AM  Q4 Scorecard and Analyst Reports for Texas Instruments & Lockheed Martin
10:21AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017
06:46AM  Wall Street's M&A Chatter From January 25
Jan-25-17 06:08PM  Abbott Laboratories Gains Despite Unimpressive Q4 Revenue Results
05:18PM  Abbott Laboratories Releases 4th-Quarter Results
12:23PM  Abbott tops 4Q profit forecasts, falls short on revenue
12:17PM  Abbott pauses on deals, to focus on St. Jude integration
12:12PM  EU mergers and takeovers (Jan 25) Reuters
11:18AM  Edited Transcript of ABT earnings conference call or presentation 25-Jan-17 2:00pm GMT
11:00AM  Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
11:00AM  European Commission Clears Abbott Acquisition of Alere PR Newswire
10:55AM  Siemens to pick banks for Healthineers listing - sources Reuters
10:15AM  EU clears Abbott acquisition of Alere subject to divestments Reuters
09:37AM  Abbott Laboratories (ABT): Tops Q4 Earnings, Sales in Line
09:13AM  Nutrition unit, strong dollar weigh on Abbott's sales
09:08AM  [$$] Abbott Labs Profit Rises, But Nutrition Business Struggles at The Wall Street Journal
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:58AM  Abbott Shares Dip on Mixed Fourth-Quarter Earnings
08:02AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:56AM  Abbott Labs' sales rise 2.8 pct
07:45AM  Abbott Reports Fourth-Quarter 2016 Results PR Newswire
07:37AM  Market Recon: The President's Actions Renew Belief in the Agenda
07:07AM  Q4 2016 Abbott Laboratories Earnings Release - Before Market Open
05:21AM  Futures point to a higher open on Wall Street, slew of earnings eyed at CNBC
Jan-24-17 12:45PM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
Jan-23-17 04:54PM  The Best Health Care REITs for 2017
10:36AM  Whats New with Johnson & Johnson?
08:25AM  Top Analysts Love These 5 Buy-Rated Dividend Aristocrats for 2017
Jan-20-17 06:00PM  New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients PR Newswire
05:53PM  What's in Store for Abbott Labs (ABT) This Earnings Season?
07:38AM  Why Johnson & Johnsons 4Q16 Revenues Could Grow
Jan-19-17 02:57PM  The Biggest Mergers Currently Stuck In Regulatory Purgatory
12:11PM  [$$] Abbott Set for 12% EPS Growth at Barrons.com
07:00AM  This Could Be The Biggest Winner Of 2017s Biotech Boom
Jan-18-17 10:54AM  ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation at Insider Monkey
08:00AM  Abbott Announces European Launch of the Proclaim DRG Neurostimulation System for the Management of Chronic Neuropathic Pain PR Newswire
Jan-17-17 08:00AM  New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation PR Newswire
Jan-16-17 04:08PM  Adient Stock: Still Undervalued After Johnson Controls Spinoff
11:30AM  5 Trade Ideas for Tuesday: Abbott Labs, Applied Materials, Citrix, Graco and Lowe's
Jan-14-17 12:01AM  [$$] Credit Suisse Likes Expedia's Mash-Up of Brands at Barrons.com
Jan-13-17 09:07AM  Inside Johnson & Johnsons Latest Dividend Payment
07:36AM  Understanding Johnson & Johnsons Medical Device Business Lawsuit Troubles
Jan-12-17 05:43PM  Short seller on Time Warner-AT&T
04:00PM  Abbott Announces U.S. Launch and First Commercial Use of the New EnSite Precision Cardiac Mapping System PR Newswire
09:08AM  Johnson & Johnsons Diabetes Launch to Accelerate the Medical Device Business
Jan-11-17 02:19PM  Alinity ci-series Of Diagnostic Systems From Abbott Laboratories (ABT) Obtains CE Mark at Insider Monkey
12:56PM  Analyst Reports for Facebook, Bank of America & ConocoPhillips
Jan-10-17 07:07PM  US warns of unusual cybersecurity flaw in heart devices
02:26PM  Abbott Labs Stock Trades Ex-Dividend Wednesday at Investopedia
08:15AM  Blog Coverage ReWalk Announced 2017 Outlook; to Reduce Operating Expenses by up to 30% Accesswire
07:00AM  Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems PR Newswire
07:00AM  Abbott Announces CE Mark for its "Alinity s" Blood and Plasma Screening System PR Newswire
Jan-09-17 06:34PM  St. Jude releases cyber updates for heart devices after U.S. probe Reuters
06:28PM  The Best DRIP Stocks: 15 No-Fee Dividend Aristocrats
05:27PM  [$$] Abbott's St. Jude Patches Device Software After Regulators Confirm Weaknesses at The Wall Street Journal
04:04PM  Muddy Waters' Carson Block: Announced Tech Fixes Do Not Appear To Address Many Of The Larger Problems For Abbott-St. Jude
12:36PM  St. Jude release cyber updates for heart devices after government probe Reuters
12:25PM  Abbott releases cyber updates after government probe
12:00PM  Abbott releases cyber updates for St. Jude devices after gov't probe Reuters
06:55AM  Will Johnson & Johnson Shock Investors with a Spin-off in 2017? at Motley Fool
Jan-08-17 08:35AM  Parkinson's Therapy Gets Fresh Look From Device Makers at The Wall Street Journal
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
04:25PM  ABBOTT LABORATORIES Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disp
10:33AM  Abbott Laboratories Value Analysis (NYSE:ABT) : January 5, 2017
07:35AM  How Do Wall Street Analysts View Becton Dickinson?
Jan-04-17 04:30PM  Abbott Completes the Acquisition of St. Jude Medical PR Newswire
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM